Thursday, December 19, 2024
HomeTagsInterim Response

Interim Response

Akebia Therapeutics Received Interim Response to Appeal for Vadadustat

Akebia Therapeutics, Inc., a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, announced that the company received...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics